Problems of stopping trials early

BMJ. 2012 Jun 15:344:e3863. doi: 10.1136/bmj.e3863.
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Clinical Trials Data Monitoring Committees*
  • Critical Illness
  • Decision Making
  • Endpoint Determination
  • Ethics, Research
  • Humans
  • Insulin / therapeutic use
  • Myocardial Infarction / prevention & control
  • Protein C / therapeutic use
  • Randomized Controlled Trials as Topic*
  • Research Design
  • Sepsis / drug therapy
  • Surgical Procedures, Operative / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Insulin
  • Protein C